Overview
Design of Clinical Trials
Survival Analysis
Longitudinal Data Analysis
Clustered Data Analysis
ROC Curve Analysis
Design and Analysis of Microarray Studies
Big Data Analysis
Survival Analysis
Longitudinal Data Analysis
Clustered Data Analysis
ROC Curve Analysis
Design and Analysis of Microarray Studies
Big Data Analysis
Current Appointments & Affiliations
Professor of Biostatistics & Bioinformatics
·
2006 - Present
Biostatistics & Bioinformatics, Division of Integrative Genomics,
Biostatistics & Bioinformatics
Member of the Duke Cancer Institute
·
2021 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Design and analysis of individually randomized group-treatment trials with time to event outcomes.
Journal Article Lifetime Data Anal · July 2025 In a typical individually randomized group-treatment (IRGT) trial, subjects are randomized between a control arm and an experimental arm. While the subjects randomized to the control arm are treated individually, those in the experimental arm are assigned ... Full text Open Access Link to item CiteLow intensity focused ultrasound stimulation in stroke: A phase I safety & feasibility trial.
Journal Article Brain Stimul · 2025 OBJECTIVE: We aimed to determine the maximum safe spatial-peak pulse-average intensity (ISPPA) of low-intensity focused ultrasound stimulation (LIFUS) in stroke patients and explore its effect on motor learning and corticospinal excitability. METHODS: We a ... Full text Link to item CiteRandomized Phase II Cancer Clinical Trials to Validate Predictive Biomarkers.
Journal Article Biomedicines · September 26, 2024 OBJECTIVES: The design of cancer clinical trials incorporating biomarkers depends on various factors, including the trial phase, the type of biomarker and whether its role has been validated. This article aims to present a method for designing and analyzin ... Full text Link to item CiteRecent Grants
A Phase II, Multi-centre, Randomised, Double-blind, Group Comparator Trial to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Patients with Tenosynovial Giant Cell Tumour,
Clinical TrialStatistician · Awarded by SynOx Therapeutics Ltd · 2025 - 2030Disparate Survival, Disparate Workforce: An Integrated Approach to Improving Head and Neck Cancer Outcomes and Diversity in the Oncology Workforce
ResearchBiostatistician · Awarded by National Institute of Dental and Craniofacial Research · 2024 - 2029Cascade Amplification Biosensor Technology for Detecting MicroRNA Biomarkers of Alzheimer Disease
ResearchCo Investigator · Awarded by National Institute on Aging · 2025 - 2027View All Grants
Education, Training & Certifications
University of Wisconsin, Madison ·
1992
Ph.D.